Sponsor pipeline

National Cancer Center, Japan clinical trial pipeline

Get alerts when National Cancer Center, Japan's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-14 NCT07872722 Zolbetuximab, Durvalumab, and FLOT Combination Neoadjuvant Chemotherapy for… Phase 2 Recruiting

Active trials by phase

Phase 2
9
Phase 3
1
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04328948 A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0… Esophageal Squamous Cell Carcinoma Recruiting 2025-05-22
Phase 2
NCT07872722 Zolbetuximab, Durvalumab, and FLOT Combination Neoadjuvant Chemotherapy for… CLDN18.2-Positive Gastric Cancer Recruiting 2026-10-14
NCT07699939 Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and… Gastric Adenocarcinoma Recruiting 2026-08-05
NCT06673628 Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients Angiosarcoma of Skin Recruiting 2026-06-24
NCT07347314 Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or… Advanced Small Bowel Adenocarcinoma Recruiting 2026-03-11
NCT04962867 NCCH2006/MK010 Trial (FORTUNE Trial) Advanced or Recurrent Solid Tumors Recruiting 2025-10-03
NCT06159478 Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer… Low-grade Glioma Recruiting 2023-12-13
NCT05832827 First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or… Untreated Advanced or Recurrent Thymic Carcinomas Recruiting 2023-10-23
NCT07750353 A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for… Unresectable Thymic Carcinoma Not Yet Recruiting 2026-08-06
NCT07720258 Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma… Advanced Small Bowel Adenocarcinoma Not Yet Recruiting 2026-07-22
Not specified
NCT05433753 Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting… HER2-positive Breast Cancer Recruiting 2024-03-25
NCT05217407 Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing… Rare Malignant Neoplasm Recruiting 2024-03-22
NCT06854939 A Prospective Study Investigating the Relationship Between Minimal Residual Disease… NSCLC, Stage I, II, III Not Yet Recruiting 2025-03-03

Disease areas by active trials

Gastric Cancer (2) · Breast Cancer (1) · Esophageal Cancer (1) · Glioma (1) · HER2-Positive Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1) · Sarcoma (1)

Get alerts when National Cancer Center, Japan's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free